Deputy Minister of Health Tran Van Thuan and Chairman of the Council of Hanoi Medical University Ta Thanh Van witnessed the first test injection of ARCT-154 vaccine for a volunteer. - Vietnam News/ANN
HANOI, Aug 16 (Vietnam News/ANN): The Hanoi Medical University on Sunday (Aug 15) started the phase 1 of clinical trial of the mRNA Covid-19 vaccine named ARCT-154 vaccine with 100 volunteers from Hanoi.
The self-amplifying mRNA vaccine is developed by the US-based Arcturus Therapeutics who partners with VinGroup's VinBioCare for support in clinical trials and manufacturing (at a facility in Hoa Lac Hi-tech Park, Hanoi).
Already a subscriber? Log in.
Subscribe or renew your subscriptions to win prizes worth up to RM68,000!
Cancel anytime. No ads. Auto-renewal. Unlimited access to the web and app. Personalised features. Members rewards.
Follow us on our official WhatsApp channel for breaking news alerts and key updates!
